Endogenous Opioid Peptide Release Contributes to Spinal Pain Relief From a Synthetic Opioid Drug

The potent synthetic mu-opioid [Dmt1]DALDA produced spinal analgesia partly by triggering release of endogenous opioid peptides, not solely through direct receptor activation — a drug-endogenous peptide synergy.

Szeto, Hazel H et al.·The Journal of pharmacology and experimental therapeutics·2003·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-00863Animal StudyPreliminary Evidence2003RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Intrathecal [Dmt1]DALDA analgesia was partly mediated by endogenous opioid peptide release (confirmed by opioid antiserum blocking), demonstrating drug-induced amplification through the endogenous opioid system.

Key Numbers

How They Did This

Animal study. Intrathecal [Dmt1]DALDA in mice. Antinociception measured with and without ICV/intrathecal opioid antisera to determine contribution of endogenous opioid release to the drug's analgesic effect.

Why This Research Matters

If opioid drugs work partly by triggering endogenous opioid release, this amplification could be enhanced for better pain relief at lower drug doses — reducing addiction risk.

The Bigger Picture

The best pain drugs may be those that amplify the body's own pain control rather than just directly activating receptors. This amplification principle could guide next-generation analgesic design.

What This Study Doesn't Tell Us

Mouse study. The specific endogenous opioids released were not identified. The relative contribution of direct versus endogenous activation varies by drug dose.

Questions This Raises

  • ?Can this amplification principle be exploited for safer analgesics?
  • ?Do all opioid drugs trigger endogenous peptide release?
  • ?Could combining low-dose opioids with peptidase inhibitors maximize this effect?

Trust & Context

Key Stat:
Drug triggers body's own painkillers [Dmt1]DALDA didn't just activate receptors directly — it triggered endogenous opioid release for amplified pain relief through a synergistic drug-peptide circuit
Evidence Grade:
Preliminary animal evidence with antibody blocking demonstrating endogenous contribution to exogenous drug analgesia.
Study Age:
Published in 2003. Drug-endogenous opioid synergy has been recognized as a mechanism for several analgesic drugs.
Original Title:
Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
Published In:
The Journal of pharmacology and experimental therapeutics, 305(2), 696-702 (2003)
Database ID:
RPEP-00863

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Can opioid drugs activate the body's own painkillers?

Yes — this study shows a synthetic opioid triggered release of the body's own opioid peptides, amplifying pain relief beyond what the drug alone could achieve.

Could this reduce opioid addiction risk?

Potentially. If drugs can recruit the body's own controlled pain relief system, lower drug doses might achieve the same analgesia — reducing addiction risk while maintaining effectiveness.

Read More on RethinkPeptides

Cite This Study

RPEP-00863·https://rethinkpeptides.com/research/RPEP-00863

APA

Szeto, Hazel H; Soong, Yi; Wu, Dunli; Qian, XuanXuan; Zhao, Guo-Min. (2003). Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.. The Journal of pharmacology and experimental therapeutics, 305(2), 696-702.

MLA

Szeto, Hazel H, et al. "Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.." The Journal of pharmacology and experimental therapeutics, 2003.

RethinkPeptides

RethinkPeptides Research Database. "Endogenous opioid peptides contribute to antinociceptive pot..." RPEP-00863. Retrieved from https://rethinkpeptides.com/research/szeto-2003-endogenous-opioid-peptides-contribute

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.